BDBM645220 2-((5- fluorobenzo[d]oxazol-2- yl)methyl)-6-(2-(2,2,2,- trifluoroethoxy)pyrimidin- 5-yl)pyridazin-3(2H)-one::US11873290, Compound 55

SMILES Fc1ccc2oc(Cn3nc(ccc3=O)-c3cnc(OCC(F)(F)F)nc3)nc2c1

InChI Key InChIKey=GIWUJUYRVVPJPU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 645220   

TargetDystrophin(Human)
Edgewise Therapeutics

US Patent
LigandPNGBDBM645220(US11873290, Compound 55 | 2-((5- fluorobenzo[d]ox...)
Affinity DataIC50: 1.00E+4nMAssay Description:BSA, ATP, NADH, PEP, and DTT solutions were thawed at room temperature, then transferred to ice. Pellet-frozen myofibrils (approximately twice the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2024
Entry Details
Go to US Patent

TargetDystrophin(Human)
Edgewise Therapeutics

US Patent
LigandPNGBDBM645220(US11873290, Compound 55 | 2-((5- fluorobenzo[d]ox...)
Affinity DataIC50: 5.50E+4nMAssay Description:Following example 15, the counter screen was done using frozen myofibril pellets obtained from cardiac tissue. The assay was done in the same manner ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2024
Entry Details
Go to US Patent